Clinical Trial News and Research

RSS

Aspirin changes the way colorectal cancer cells evolve over time, study reveals

Cancer starts when cells start dividing uncontrollably. Scientists have known that taking aspirin can help protect against the development of colorectal cancer – cancer afflicting the colon or rectum – but the exact reason aspirin has this effect has been mostly a mystery.

9 Jun 2022

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

The number of reported cases using viruses to treat deadly Mycobacterium infections just went up by a factor of five. In a new study, a team led by researchers from the University of Pittsburgh and the University of California San Diego report 20 new case studies on the use of the experimental treatment, showing the therapy's success in more than half of the patients.

9 Jun 2022

Insilico Medicine plans to launch a fully automated AI-driven robotics lab for drug discovery

Insilico Medicine's end-to-end AI-driven drug discovery platform, Pharma.AI, draws its strength from the quality and quantity of its data. As Insilico scientific advisory board member and Nobel Prize laureate in chemistry Dr. Michael Levitt has said, Insilico's platform capitalizes on the ability of artificial intelligence to take vast amounts of data from many different components and find patterns and make predictions that can point the way to new life-saving medications.

9 Jun 2022

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Testosterone replacement therapy appears safe in the short-to-medium term to treat a condition caused by deficiency of the male sex hormone, according to the most comprehensive analysis of the treatment to date, published in The Lancet Healthy Longevity journal.

9 Jun 2022

Whole-body learning has a positive impact on children's ability to learn letter sounds

Children who move while learning sounds of letters significantly improve their ability to recognize individual letter sounds.

8 Jun 2022

New study into sepsis could save children’s lives around the world

A clinical study examining new ways of treating children with sepsis - using vitamin C and steroids alongside antibiotics - could save children's lives around the world.

8 Jun 2022

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

In a recent study published in the Lancet, researchers evaluated the safety and efficacy of tixagevimab–cilgavimab, a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-neutralizing monoclonal antibody (mAb) combination in patients with mild to moderate coronavirus disease 2019 (COVID-19).

8 Jun 2022

Zinc may reverse lung damage, improve survival for patients with idiopathic pulmonary fibrosis

Investigators from the Women's Guild Lung Institute at Cedars-Sinai have discovered that zinc, a common mineral, may reverse lung damage and improve survival for patients with a deadly age-related condition known as idiopathic pulmonary fibrosis (IPF).

8 Jun 2022

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Vaccinating household chicken flocks can increase availability and consumption of eggs and meat, leading to better growth of young children in agriculture-dependent families in rural Kenya.

8 Jun 2022

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Racial and ethnic minorities diagnosed with advanced liver cancer have a lower chance of receiving immunotherapy, the most effective treatment for patients with the disease, according to a new study led by Cedars-Sinai Cancer investigators.

8 Jun 2022

Vegan diet leads to decreased weight and improved insulin sensitivity

A vegan diet improves diet quality, leading to decreased weight and improved insulin sensitivity, according to a new study by the Physicians Committee for Responsible Medicine published in the Journal of the Academy of Nutrition and Dietetics.

8 Jun 2022

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Adults who survive childhood cancer have a higher risk of cardiovascular disease than the general population, yet they are 80% more likely to be undertreated for several cardiovascular risk factors: hypertension (also called high blood pressure), diabetes and high cholesterol, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

8 Jun 2022

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

A medical research team from the University of Hong Kong (HKU) will start a large-scale clinical trial on a new COVID-19 inactivated vaccine (Omicron variant) developed by China National Biotec Group (Sinopharm).

8 Jun 2022

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

The National Institute on Aging, a division of the National Institutes of Health, awarded Berislav Zlokovic, MD, PhD, director of the Zilkha Neurogenetic Institute, and Arthur W. Toga, PhD, director of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), $16.1 million to continue research on the role that blood vessel dysfunction plays in the development of dementia and Alzheimer's disease.

7 Jun 2022

Ketogenic diets may help ward off polycystic kidney disease

The team of UC Santa Barbara biochemist Thomas Weimbs published the results of a clinical study that gives the first indication that ketogenic diets may be safe and effective in patients with polycystic kidney disease (PKD).

7 Jun 2022

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Momelotinib, an oral pill taken once a day, significantly improved outcomes of patients treated for myelofibrosis (MF), a rare but fatal bone marrow cancer, researchers reported June 7.

7 Jun 2022

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

On Tuesday, June 7, Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center, will present the long-term results of a phase 2 clinical trial combining crenolanib, a second-generation FLT3 inhibitor, with standard intensive chemotherapy for treatment of adults with newly diagnosed FLT3-mutant acute myeloid leukemia (AML).

6 Jun 2022

Added-sugar warning labels on restaurant menus may help consumers to reach for healthier items

Do you really want to order a soda with your burger? Just one soda can have more added sugar than the entire daily limit recommended for most adults.

6 Jun 2022

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Patients with multiple myeloma who have been treated with a three-drug combination therapy have a growing number of choices for subsequent treatment. Results of a new study led by researchers at Dana-Farber Cancer Institute can help patients and their physicians weigh benefits and risks of each option.

6 Jun 2022

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Study results from three clinical trial sites show that a WW International, Inc. ("WeightWatchers" or "WW") program tailored for people living with diabetes helped participants lose weight, lower blood glucose levels, and improve their overall well-being.

6 Jun 2022

Clinical Trial News and Research

Aspirin changes the way colorectal cancer cells evolve over time, study reveals

Largest-ever series of case studies shows phage therapy’s success in more than half of the patients

Insilico Medicine plans to launch a fully automated AI-driven robotics lab for drug discovery

Analysis finds little proof that testosterone treatment increases the risk of cardiovascular events

Whole-body learning has a positive impact on children's ability to learn letter sounds

New study into sepsis could save children’s lives around the world

Safety and efficacy of tixagevimab–cilgavimab in preventing severe COVID

Zinc may reverse lung damage, improve survival for patients with idiopathic pulmonary fibrosis

Chicken vaccination leads to better growth of Kenyan children in agriculture-dependent families

Black, Hispanic patients with advanced liver cancer have lower chance of receiving immunotherapy

Vegan diet leads to decreased weight and improved insulin sensitivity

Childhood cancer survivors 80% more likely to be undertreated for cardiovascular risk factors

Researchers plan to commence a clinical trial on new COVID-19 inactivated vaccine

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

Ketogenic diets may help ward off polycystic kidney disease

Oral pill taken once a day improves outcomes of patients with myelofibrosis

Promising results of combination treatment for acute myeloid leukemia to be presented at ASCO 2022

Added-sugar warning labels on restaurant menus may help consumers to reach for healthier items

Three-drug therapy with autologous stem cell transplant improves progression-free survival for multiple myeloma patients

Diabetes-tailored program produces meaningful effects on glycemic control, body weight

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer